BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12883080)

  • 1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and posttranslational modification of p27kip1 in lipopolysaccharide-activated B cells.
    Crawford RB; Sulentic CE; Yoo BS; Kaminski NE
    Toxicol Sci; 2003 Oct; 75(2):333-42. PubMed ID: 12883080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
    Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
    Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
    Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
    J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
    Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
    Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.
    Salisbury RL; Sulentic CE
    Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
    North CM; Crawford RB; Lu H; Kaminski NE
    Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion.
    Karras JG; Morris DL; Matulka RA; Kramer CM; Holsapple MP
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):275-84. PubMed ID: 8661353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
    Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
    J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Karras JG; Holsapple MP
    Toxicol Appl Pharmacol; 1994 Apr; 125(2):264-70. PubMed ID: 8171434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes astrocyte activation and the secretion of tumor necrosis factor-α via PKC/SSeCKS-dependent mechanisms.
    Zhang Y; Nie X; Tao T; Qian W; Jiang S; Jiang J; Li A; Guo A; Xu G; Wu Q
    J Neurochem; 2014 Jun; 129(5):839-49. PubMed ID: 24673440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
    Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions at a dioxin responsive element (DRE) and an overlapping kappaB site within the hs4 domain of the 3'alpha immunoglobulin heavy chain enhancer.
    Sulentic CE; Kang JS; Na YJ; Kaminski NE
    Toxicology; 2004 Aug; 200(2-3):235-46. PubMed ID: 15212819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
    De Abrew KN; Kaminski NE; Thomas RS
    Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
    Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
    Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3,7,8-tetrachlorodibenzo-p-dioxin, an exogenous modulator of the 3'alpha immunoglobulin heavy chain enhancer in the CH12.LX mouse cell line.
    Sulentic CE; Zhang W; Na YJ; Kaminski NE
    J Pharmacol Exp Ther; 2004 Apr; 309(1):71-8. PubMed ID: 14718603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin following endotoxin exposure.
    Patterson RM; Stachlewitz R; Germolec D
    Toxicol Appl Pharmacol; 2003 Jul; 190(2):120-34. PubMed ID: 12878042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of membrane and secreted immunoglobulin during the in vitro differentiation of the murine B cell lymphoma CH12.
    Stockdale AM; Dul JL; Wiest DL; Digel M; Argon Y
    J Immunol; 1987 Nov; 139(10):3527-35. PubMed ID: 3500220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.